Hutch News

Hutch News

Stories tagged 'Cancer etiology - prevention - outcomes'

Endometriosis linked to childhood abuse

New Fred Hutch collaboration highlights yet another poor health outcome associated with adverse childhood experiences

July 17, 2018 | By Diane Mapes / Fred Hutch News Service

A new study led by Fred Hutch epidemiologist Dr. Holly Harris found an association between childhood abuse and endometriosis. Women reporting severe to chronic abuse had a 79 percent higher risk of developing the condition.

View story >


Acupuncture can curb treatment-related joint pain in breast cancer patients

Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug

July 10, 2018 | By Diane Mapes / Fred Hutch News Service

Results from a large multicenter trial published today in JAMA offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.

View story >


5 tips for a healthy summer (and life)!

From bench to beachside: Empower yourself with evidenced-based cancer-prevention science

June 29, 2018 | By Diane Mapes / Fred Hutch News Service

Want to make this your healthiest summer yet? Empower yourself — and your loved ones — with some disease-squelching science and practical prevention tips from Fred Hutch public health researchers.

View story >


HICOR receives 2-year, $250K award to boost patient engagement

Award to health economics group aims to strengthen the role of patients in research

June 13, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch’s health economics group, the Hutchinson Institute for Cancer Outcomes Research, has received a $249,882 two-year award from PCORI, the Patient-Centered Outcomes Research Institute.

View story >


At half the cost, Canadian colorectal cancer survival similar to U.S.

Cross-border collaboration compared findings in British Columbia and Washington state

June 1, 2018 | By Sabin Russell / Fred Hutch News Service

In a rare comparison of cancer care in neighboring regions of the U.S. and Canada, a new study found Americans were paying twice as much for similar colorectal cancer treatments, with no advantage in survival rates.

View story >


Biologics and biosimilars step onto the cancer therapy stage

Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?

May 31, 2018 | By Diane Mapes / Fred Hutch News Service

Costly biologics and their "generic-ish" counterparts, biosimilars, are about to step into the pharmaceutical spotlight in a big way. We sat down with Fred Hutch's Dr. Gary Lyman, an oncologist and national thought leader on health economics, to learn more about burgeoning biopharmaceuticals.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.